Medtech Trends 2026: Strategic Implications for the Global South

How global pricing shifts, care migration, supply chain resilience, metabolic therapies, and platform technologies could reshape healthcare and development

Executive Summary

The medical technology sector is entering an era of accelerated change, driven by structural forces across pricing, care delivery, supply chains, clinical pathways, and enabling technologies. While these trends are global, their impact on the Global South is distinct. For emerging economies, medtech is not only a matter of public health but also a strategic sector for industrialization, local value creation, and regional cooperation. This article examines five key medtech trends expected to influence global markets in 2026 and analyses their implications for developing countries, focusing on opportunities for domestic innovation, industrial policy, and inclusive healthcare transformation.

Introduction

Medical technology has become central to the modernization of health systems worldwide. In the Global South, where health infrastructure gaps and resource constraints are pervasive, the strategic adoption of medtech can accelerate progress toward universal health coverage and sustainable development. However, the global medtech landscape is shifting in ways that demand careful analysis. From procurement reforms in China to the rise of outpatient care in the United States, decisions made in major economies are reshaping market dynamics, pricing, and manufacturing footprints. These changes carry both risks and opportunities for emerging economies seeking to harness technology for long-term development.

Background & Context

The global medtech market is increasingly influenced by policies and innovations originating in large economies. Mainland China's volume-based procurement (VBP) reforms have evolved from a cost-containment tool into a powerful market-structuring mechanism, while the United States continues to push procedures toward ambulatory surgical centers (ASCs), reflecting a global trend toward value-based care. At the same time, supply chain vulnerabilities exposed by recent geopolitical and economic shocks have prompted manufacturers to diversify sourcing and pursue multi-region production strategies. These shifts occur alongside the rapid adoption of GLP-1 therapies for metabolic diseases and the emergence of platform-based competition driven by robotics, imaging, and digital workflows. Together, these trends are redefining the competitive landscape of the medical technology sector.

Main Analysis

#### 1. China's VBP Expansion: A Lesson in Strategic Pricing and Local Innovation

Mainland China's latest national volume-based procurement round marks a consequential shift in global medtech pricing. Originally intended to expand patient access and curb device costs, the program has evolved into a mechanism that influences price expectations and competitive positioning in markets well beyond the country. The new rules introduce more sophisticated anchor-price logic, deeper price compression, and allocation systems that support domestic manufacturers. For the Global South, the VBP model offers a potential template for balancing cost containment with support for local companies. However, it also raises questions about the long-term sustainability of aggressive price cuts and the ability of local firms to compete without equivalent economies of scale. Policymakers in emerging economies can study China's approach to design procurement policies that promote access while fostering domestic industrial capacity.

#### 2. The Migration of Procedures to Outpatient Settings: Implications for Health System Design

The continued migration of procedures from hospitals to outpatient settings is a defining medtech trend. The U.S. Centers for Medicare & Medicaid Services (CMS) 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Final Rule expands the ASC Covered Procedure List and phases out the inpatient-only list, paving the way for higher-acuity procedures to move into lower-cost settings. While this is a U.S.-specific policy, its logic resonates with health system challenges in the Global South, where hospital capacity is often scarce and out-of-pocket costs are high. Emerging economies can draw lessons from the ASC model to redesign care pathways, reduce facility overheads, and improve surgical access, particularly in remote and underserved regions.

#### 3. Supply Chain Resilience: An Opportunity for Local Manufacturing

Tariff exposure, geopolitical factors, and fluctuating material costs are challenging long-standing assumptions about where and how medical devices should be produced. These pressures are prompting companies to diversify sourcing, re-evaluate business strategies, and pursue more flexible multi-region manufacturing footprints. Larger manufacturers are also using scale, integration, and technology investment to buffer against global volatility. For the Global South, this rebalancing represents a strategic window. Countries with robust industrial policies, improving infrastructure, and a skilled workforce could attract medtech investment and become new nodes in global value chains. By fostering special economic zones, strengthening intellectual property protections, and investing in technical education, developing economies can enhance their role as manufacturing and innovation hubs.

#### 4. GLP-1 Therapies: Transforming Metabolic Care and Beyond

The rapid adoption of glucagon-like peptide-1 (GLP-1) receptor agonists for weight management is altering patient behavior and care pathways worldwide. While bariatric surgery remains the most effective intervention for substantial weight loss, GLP-1s have expanded in popularity, changing referral patterns and influencing demand across adjacent medtech categories. In the Global South, rising rates of obesity, diabetes, and related comorbidities make these therapies highly relevant. However, their high cost, the need for continuous use, and inadequate health financing pose significant barriers. The downstream effects on medical devices—such as diagnostic tools, cardiovascular monitoring, and sleep apnea equipment—are just beginning to emerge. This trend highlights the importance of robust regulatory frameworks, pricing negotiations, and local production capacity to ensure equitable access in developing countries.

#### 5. Enabling Technologies and Platform-Based Competition

Enabling technologies including robotics, imaging, navigation, and digital workflow software are reshaping how medtech companies differentiate and compete. These technologies are becoming central to integrated ecosystems that support clinical planning, surgical execution, and postoperative care. Companies are investing in platform architectures that anchor service lines, strengthen customer relationships, and enable data-driven value propositions. Open-platform systems are also expanding flexibility, creating new competitive dynamics. For the Global South, the adoption of these technologies can accelerate the digital transformation of health systems, support remote care, and foster local innovation ecosystems. Yet the digital divide, inadequate infrastructure, and high costs remain critical challenges. Strategic investments in digital health infrastructure and regional cooperation can help bridge these gaps and enable developing countries to participate in the platform economy.

Development Impact

The medtech trends discussed have direct implications for economic development, industrialization, and technology adoption. They affect employment through the creation of new manufacturing and service jobs, particularly in emerging markets that attract supply chain shifts. Foreign direct investment opportunities may arise for countries that position themselves as competitive production bases. Innovation ecosystems can be strengthened through knowledge transfer and domestic research and development. Additionally, efficient procurement and care delivery models can improve financial inclusion in health systems and free resources for other development priorities. Long-term competitiveness in healthcare will increasingly depend on a country's ability to integrate technological and industrial policies.

Global South Perspective

Across Africa, Latin America, South Asia, Southeast Asia, the Middle East, and the Pacific, the response to these medtech trends will vary based on existing industrial capacity, regulatory environments, and health system needs. Some countries may use supply chain shifts to attract investment in manufacturing; others may prioritize digital health adoption to improve access in low-resource settings. South-South cooperation is vital for sharing best practices, negotiating better terms with global manufacturers, and building collective resilience. Regional institutions such as development banks can play a catalytic role in financing infrastructure and industrial projects, while the BRICS framework and other partnerships can amplify the voice of emerging economies in global health governance. The growing role of domestic medtech firms in China and other emerging markets provides a model for knowledge sharing and joint ventures.

Future Outlook

Over the next five to ten years, the relationship between the Global South and the medtech industry will deepen. Advancements in artificial intelligence, digital infrastructure, and automation will enable more inclusive healthcare models, while the ongoing reconfiguration of global supply chains offers a once-in-a-generation opportunity for industrialization. The pace of structural transformation will depend on policy choices, investment in human capital, and the effectiveness of regional integration. Development finance must align with these priorities to support sustainable healthcare infrastructure. As emerging economies strengthen their innovation ecosystems, they could transition from being recipients of technology to co-creators of solutions tailored to local needs. The Global South's role in the global medtech landscape will be shaped not only by market forces but also by strategic partnerships and institutional evolution.

Conclusion

The evolving medtech landscape presents both challenges and opportunities for the Global South. By understanding and responding to global trends, policymakers, industry leaders, and development institutions can turn healthcare transformation into a driver of sustainable growth and human development. The key lies in fostering an ecosystem where technological adoption, local innovation, industrial policy, and regional cooperation work in tandem. Medtech is not merely a sector; it is a catalyst for broader economic and social progress across emerging markets.

Key Takeaways

• China's VBP expansion demonstrates how strategic procurement can balance cost control and domestic industry support.
• Outpatient care models offer lessons for improving efficiency and expanding surgical access in developing health systems.
• Supply chain rebalancing opens a window for emerging economies to attract medtech manufacturing investments.
• GLP-1 therapy adoption underscores the need for equitable access and local production of advanced treatments.
• Platform-based technologies present opportunities for digital leapfrogging, but require investment in infrastructure and skills.

SEO Keywords

Global South, Emerging Markets, Medtech Trends, Medical Technology, Healthcare Innovation, Industrial Policy, Supply Chain Resilience, Digital Health, Development Finance, South-South Cooperation

Source

This article is based on the Clarivate report Medtech Trends to Watch 2026 (https://clarivate.com/life-sciences-healthcare/blog/5-medtech-trends-to-watch-in-2026) and uses publicly available information for analysis. The original report was not altered or misrepresented.